Wealth management trust engagement with biotech IPOs has
Wealth management trust engagement with biotech IPOs has increased, with two new listings up over 50% since debut. Portfolio beta risk is higher but justified by pipeline valuations. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. The latest moves, appointments and personnel changes in wealth management in North America. Wealth management trust allocations shifted toward defensive consumer staples amid market uncertainty. Procter & Gamble’s revenue beat (+3% YoY) reinforces stable dividend yield strategies within trust-managed accounts.
Return this item for free
We offer easy, convenient returns with at least one free return option: no shipping charges. All returns must comply with our returns policy.
Learn more about free returns.- Go to your orders and start the return
- Select your preferred free shipping option
- Drop off and leave!